Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Carcinoma, Renal Cell 15Melanoma 12HIV Infections 6Acquired Immunodeficiency Syndrome 6Sarcoma, Kaposi 5Lymphoma 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Triple Negative Breast Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Multiple Myeloma 2Leukemia, Myeloid, Chronic-Phase 2Leukemia 2Kidney Neoplasms 2Hematologic Neoplasms 2Uveal Melanoma 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Tumor Virus Infections 1Thrombocythemia, Essential 1Solid Cancers 1Skin Neoplasms 1Sarcoma 1Polycythemia Vera 1Peritoneal Neoplasms 1Papillomavirus Infections 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasm Metastasis 1

Interventions

Peripheral Blood Stem Cell Transplantation 28fludarabine phosphate 26Cyclophosphamide 20Whole-Body Irradiation 17Mycophenolic Acid 17Cyclosporine 17Tacrolimus 15Busulfan 13Methotrexate 11Antilymphocyte Serum 10Radiotherapy 8Methylprednisolone 8Filgrastim 8Etoposide 8Flow Cytometry 7Bexarotene 7Vorinostat 6Bortezomib 6Psychiatric Rehabilitation 5Everolimus 5Dexamethasone 5Carboplatin 5Alemtuzumab 5hypericin 4fludarabine 4Transplantation 4Therapeutics 4Polymerase Chain Reaction 4Panobinostat 4Lenalidomide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Mycosis Fungoides × Interferon alpha-2 × Clear all
NCT00038376 2018-10-29

Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies

M.D. Anderson Cancer Center

Phase 2 Completed
56 enrolled
LymphoidOther hematologic neoplasm

Mycosis Fungoides, Lymphoma, T-Cell, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡